Please login to the form below

Not currently logged in
Email:
Password:

ConfometRx

This page shows the latest ConfometRx news and features for those working in and with pharma, biotech and healthcare.

UCB signs research deal for novel neuroscience drugs

UCB signs research deal for novel neuroscience drugs

UCB signs research deal for novel neuroscience drugs. Partners with structural biology company ConfometRx. ... The Belgium-based biopharma firm is collaborating with ConfometRx, a California-based company that was co-founded by Stanford University

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics